Characterizing Follicles From Auto-transplanted Ovarian Tissue

Sponsor
Peter Humaidan (Other)
Overall Status
Recruiting
CT.gov ID
NCT04905771
Collaborator
Reproduktionsbiologisk Laboratorium, JMC, Rigshospitalet, København (Other)
10
1
60
0.2

Study Details

Study Description

Brief Summary

The aim of the project is to characterize the hormonal conditions in egg follicles in women who, prior to fertility treatment, have had autotransplanted frozen ovarian tissue for the purpose of fertility preservation.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    10 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Characterizing Follicles From Auto-transplanted Ovarian Tissue
    Actual Study Start Date :
    Feb 1, 2021
    Anticipated Primary Completion Date :
    Feb 1, 2026
    Anticipated Study Completion Date :
    Feb 1, 2026

    Outcome Measures

    Primary Outcome Measures

    1. Characterize hormone production in follicles from autotransplanted ovarian tissue [5 years]

      Women undergoing fertility treatment

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 42 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Women aged 18 years or older

    • Has had frozen and later autotransplanted ovarian tissue for fertility preservation purposes

    • Included in fertility treatment with eff retrieval at the Fertility Clinic Regional Hospital Skive

    • Is willing and able to give informed consent

    Exclusion Criteria:
    • Patients undergoing fertility treatment but have not received autotransplanted ovarian tissue for fertility preservation purposes

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fertility Clinic, Skive Regional Hospital Skive Denmark

    Sponsors and Collaborators

    • Peter Humaidan
    • Reproduktionsbiologisk Laboratorium, JMC, Rigshospitalet, København

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Peter Humaidan, Professor, Regionshospitalet Viborg, Skive
    ClinicalTrials.gov Identifier:
    NCT04905771
    Other Study ID Numbers:
    • OTT-study2021
    First Posted:
    May 28, 2021
    Last Update Posted:
    Jun 15, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Peter Humaidan, Professor, Regionshospitalet Viborg, Skive
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 15, 2022